Skip to main content
Caplight Logo









Crohn's & Colitis Foundation

Crohn's & Colitis Foundation

New York City, New Yorkcrohnscolitisfoundation.org

Overview

Crohn's & Colitis Foundation is a non-profit organization dedicated to finding cures for Crohn's disease and ulcerative colitis and improving the quality of life of children and adults affected by these diseases through research funding, education, and support.

Year Founded

1967

Portfolio Companies

9

Investments

Crohn's & Colitis Foundation investments
CompanyDateStageLead
11 Health and TechnologiesJan 2022GrantCo-investor
Gusto Global-GrantCo-investor
InotremNov 2023GrantCo-investor
Exeliom BiosciencesMar 2024GrantCo-investor
Giiant Pharma Inc.Jan 2023GrantCo-investor
Book a demo to see all 9 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Crohn's & Colitis Foundation based?

Crohn's & Colitis Foundation is headquartered in New York City, New York, United States.

When was Crohn's & Colitis Foundation founded?

Crohn's & Colitis Foundation was founded in 1967.

How many portfolio companies does Crohn's & Colitis Foundation have?

Crohn's & Colitis Foundation has 9 portfolio companies in Caplight's dataset.

What are some companies in Crohn's & Colitis Foundation's portfolio?

Portfolio companies visible on Caplight include 11 Health and Technologies, Gusto Global, Inotrem, Exeliom Biosciences, Giiant Pharma Inc..

What was Crohn's & Colitis Foundation's most recent investment shown here?

Crohn's & Colitis Foundation's most recent investment in this portfolio sample was in Exeliom Biosciences in 2024.

What sectors does Crohn's & Colitis Foundation focus on?

Crohn's & Colitis Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.

What company stages does Crohn's & Colitis Foundation focus on?

Crohn's & Colitis Foundation typically invests at the MultiStage stage.

What is Crohn's & Colitis Foundation's AUM?

Crohn's & Colitis Foundation's assets under management are estimated between $0.0 and $50.0M.

Firmographic Details

HeadquartersNew York City, New York
Year Founded1967

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?